2024
Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities
Valdez C, Sánchez-Zuno G, Bucala R, Tran T. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities. International Journal Of Molecular Sciences 2024, 25: 4849. PMID: 38732068, PMCID: PMC11084905, DOI: 10.3390/ijms25094849.Peer-Reviewed Original ResearchConceptsInhibition of MIFResponse to infectionNon-canonical signaling pathwaysClinical studiesCancer patientsClinical trialsInflammatory cytokinesDriving tumorigenesisClinical explorationCancer typesCancerDual inhibitionTherapeutic targetIn vivoIn vitroSignaling pathwayMIFAntitumor candidateBinding partners
2000
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)
Mitchell R, Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Seminars In Cancer Biology 2000, 10: 359-366. PMID: 11100884, DOI: 10.1006/scbi.2000.0328.Peer-Reviewed Original ResearchConceptsMacrophage migration inhibitory factorMigration inhibitory factorInhibitory factorPotent pro-inflammatory cytokinePro-inflammatory cytokinesInflammatory responseTumor progressionTumor angiogenesisTumor suppressor activitySuppressor activityCell proliferationRecent studiesGrowth-promoting propertiesCytokinesNeoplasiaMultiple aspectsProgression
1999
An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect
Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han J, Metz C, Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect. Proceedings Of The National Academy Of Sciences Of The United States Of America 1999, 96: 3047-3052. PMID: 10077634, PMCID: PMC15892, DOI: 10.1073/pnas.96.6.3047.Peer-Reviewed Original ResearchMeSH Keywords3' Untranslated RegionsAllosteric RegulationAmino Acid SequenceBase SequenceCell DivisionCell Transformation, NeoplasticCloning, MolecularGene Expression Regulation, NeoplasticGlycolysisHumansMolecular Sequence DataNeoplasmsPhosphofructokinase-2Phosphotransferases (Alcohol Group Acceptor)RNA, MessengerSequence AlignmentTumor Cells, CulturedConceptsGene productsWarburg effectAU-rich instability elementsMRNA instability motifsInducible gene productsTissue-specific isoformsImportant control pointPentose phosphate pathwayNucleic acid biosynthesisHigh glycolytic rateAcid biosynthesisInducible genesInstability motifsTumor cell glycolysisAllosteric regulatorsPhosphate pathwayPFK-2Tumor cell growthInstability elementMultiple copiesCell growthCancer cell linesEnhanced glycolysisCell glycolysisHuman cancer cell lines
1997
Tobacco smoke is a source of toxic reactive glycation products
Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R, Cerami A. Tobacco smoke is a source of toxic reactive glycation products. Proceedings Of The National Academy Of Sciences Of The United States Of America 1997, 94: 13915-13920. PMID: 9391127, PMCID: PMC28407, DOI: 10.1073/pnas.94.25.13915.Peer-Reviewed Original ResearchConceptsAdvanced glycation end productsTobacco smokeGlycation productsAGE formationSerum AGE levelsIncidence of atherosclerosisPlasma of patientsGlycation end productsRenal insufficiencyCerebrovascular diseaseCigarette smokersHuman smokersHigh prevalenceHigh riskSmokersNonsmokersGlycotoxinsPatientsSpecific fluorescenceSerum proteinsDiseaseCuring of tobaccoAqueous extractSmokeTobacco